Status:
COMPLETED
Dance Movement Therapy for Radio-oncological Patients
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Cancer Patients and Physical Activity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dance-RT-01 investigates the feasibility and effects of Integrative, resource-oriented short term Dance Movement Therapy (DMT) in radio-oncological patients shortly after radiotherapy (RT). The study ...
Detailed Description
The study is designed as investigator-initiated, prospective, non-randomized feasibility trial and includes radio-oncological patients (ECOG 0-2) who recently completed RT. The primary endpoint is to ...
Eligibility Criteria
Inclusion
- Male and female oncological patients
- Age at least 18 years. No upper age limit
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- Written informed consent for participation in the study
- Prior RT received shortly before study inclusion (therapy completed)
- Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including
Exclusion
- Inability to speak and understand German
- Serious concurrent neurologic or psychiatric disorders: dementia, uncontrolled seizures, psychosis, schizophrenia, neurosis, autism that would interfere with cooperation with the requirements of the trial
- Familial, sociological, or geographical condition that would preclude study compliance (these conditions should be discussed with the patient before registration in the study)
- Has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the study team
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Is pregnant or breastfeeding, or expecting to conceive
Key Trial Info
Start Date :
February 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2025
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT07001033
Start Date
February 22 2025
End Date
April 20 2025
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology, Translational Radiobiology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Bavaria, Germany, 91054